Prognostic value of HLA-I homozygosity in patients with non-small cell lung cancer treated with single agent immunotherapy

Background We aimed to assess the impact of genomic human leukocyte antigen (HLA)-I/II homozygosity on the survival benefit of patients with unresectable locally advanced, metastatic non-small lung cancer treated by single-agent programmed cell death protein-1/programmed death ligand 1 (PD1/PDL1) in...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Mark Watson, Michael Millward, Samantha Bowyer, Afaf Abed, Leslie Calapre, Johnny Lo, Suzana Correia, Abha Chopra, Muhammad Adnan Khattak, Elin Solomonovna Gray
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMJ Publishing Group 2020-10-01
Edice:	Journal for ImmunoTherapy of Cancer
On-line přístup:	https://jitc.bmj.com/content/8/2/e001620.full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!